Literature DB >> 639231

Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy.

R A Winkle.   

Abstract

Twenty patients with frequent ventricular ectopic beats had a 5 1/2 hour ECG rhythm strip recorded. Individual patients showed a marked spontaneous variability from one half-hour to the next in the total number of ectopic beats (-99% to +1100%) and the occurrence of pairs or salvos. Although no patient received antiarrhythmic drugs, some patients showed a spontaneous change in arrhythmia which mimicked either drug suppression or drug-induced worsening of arrhythmias. If an antiarrhythmic drug had been given to these patients after the first half-hour, 65% would have been termed "drug responders," using the criteria of 50% reduction in ectopic beats and elimination of pairs or salvos during any half-hour period in the subsequent three hours. Spontaneous variability in ventricular ectopic beats causes serious problems when using ECG monitoring to evaluate antiarrhythmic drug response in individual patients. The arrhythmias averaged for the entire group remained stable during the recording period. Evaluating antiarrhythmic drugs by examining group response rather than individual patient response minimizes the effect of spontaneous variability.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 639231     DOI: 10.1161/01.cir.57.6.1116

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Recurrent ventricular tachycardia.

Authors:  D E Ward; J Camm
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-29

2.  Efficacy and tolerance of tocainide during acute and long-term treatment of chronic ventricular arrhythmias.

Authors:  C Sonnhag
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

Review 3.  Therapeutic drug monitoring of antiarrhythmic agents.

Authors:  J E Brown; D G Shand
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

4.  Holter monitoring.

Authors:  E Guirguis
Journal:  Can Fam Physician       Date:  1987-04       Impact factor: 3.275

Review 5.  Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.

Authors:  A Fitton; M T Buckley
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

6.  Repeatability of ectopic beats from 48-hr ambulatory electrocardiography: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Michelle L Meyer; Elsayed Z Soliman; Lisa M Wruck; Thomas H Mosley; Lynne E Wagenknecht; Anna K Poon; Eric A Whitsel; Alvaro Alonso; Gerardo Heiss; Laura R Loehr
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-01-06       Impact factor: 1.468

7.  Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.

Authors:  H Drexler; H Löllgen; H Just
Journal:  Klin Wochenschr       Date:  1981-06-15

8.  The effects of chronic oral cimetidine therapy on the cardiovascular system in man.

Authors:  S Saltissi; A Crowther; C Byrne; D J Coltart
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

9.  Increased cardiac electrical instability concomitant with pacing induced repolarisation abnormalities.

Authors:  P Della Bella; S Grazi; C M Cipolla; F Fabbiocchi; A Rimondini; P Sganzerla; M D Guazzi
Journal:  Br Heart J       Date:  1987-02

10.  Prajmalium bitartrate in chronic ventricular arrhythmias: comparison with disopyramide.

Authors:  M Chiariello; C Indolfi; M Cappelli Bigazzi; M Condorelli
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.